Targeted and Localized Cancer Drug Release Kinetics from Microporous Poly-di-methyl-siloxane (PDMS) Devices: in-vivo Studies for the Treatment of Triple Negative Breast Cancer
Stanley Eluu,
Danyuo Yiporo,
Ali Salifu
et al.
Abstract:Triple-negative breast cancer (TNBC) treatment is challenging and frequently characterized by an aggressive phenotype and low prognosis in comparison to other subtypes. This paper presents an implantable microporous poly-di-methyl-siloxane device for the delivery of targeted therapeutic agents (LHRH-paclitaxel and LHRH-prodigiosin) for the treatment and possible prevention of triple-negative cancer recurrence. The possible cytotoxic effects of the drugs on liver, kidney, and lung tissues are also assessed. Dru… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.